Literature DB >> 31918285

MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12.

Shaoshan Han1, Liang Wang1, Liankang Sun1, Yufeng Wang1, Bowen Yao1, Tianxiang Chen1, Runkun Liu1, Qingguang Liu2.   

Abstract

MicroRNAs (miRNA) are small RNA molecules that have emerged as important regulators of gene expression in hepatocellular carcinoma (HCC). However, the expression, function and mechanism of miR-1251-5p in HCC remain poorly understood. In the present study, it was observed that miR-1251-5p expression was upregulated in HCC. Furthermore, higher miR-1251-5p level was correlated with poor prognosis, large tumor size, vascular invasion and high tumor-node-metastasis (TNM) stages of HCC patients. Functionally, miR-1251-5p drove HCC cell proliferation, migration and invasion in vitro, and promoted growth and metastasis of HCC cells in vivo. A-kinase anchor protein 12 (AKAP12) was screened as a direct target of miR-1251-5p by using the starBase V3.0 online platform. The AKAP12 mRNA expression was downregulated and negatively correlated with miR-1251-5p level in HCC tissues. Furthermore, in vitro experiments confirmed that AKAP12 was targeted and negatively regulated by miR-1251-5p. Importantly, AKAP12 overexpression decreased HCC cell proliferation, migration and invasion, whereas inhibition of AKAP12 rescued the miR-1251-5p knockdown-attenuated HCC cell proliferation, migration and invasion. Overall, the present study indicates that miR-1251-5p plays an oncogenic role in HCC by targeting AKAP12, and may be a potential therapeutic target for HCC treatment.
Copyright © 2019 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  AKAP12; Growth; HCC; Metastasis; MiR-1251-5p

Year:  2019        PMID: 31918285     DOI: 10.1016/j.biopha.2019.109754

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  AKAP12 ameliorates liver injury via targeting PI3K/AKT/PCSK6 pathway.

Authors:  Xuan Wu; Yuhong Luo; Shan Wang; Yueying Li; Meiyu Bao; Yuanjiang Shang; Lei Chen; Weiwei Liu
Journal:  Redox Biol       Date:  2022-05-06       Impact factor: 10.787

2.  Upregulated PPARG2 facilitates interaction with demethylated AKAP12 gene promoter and suppresses proliferation in prostate cancer.

Authors:  Feng Li; Tingting Lu; Dongmei Liu; Chong Zhang; Yonghui Zhang; Fulu Dong
Journal:  Cell Death Dis       Date:  2021-05-22       Impact factor: 8.469

Review 3.  Molecular Mechanism and Approach in Progression of Meningioma.

Authors:  Zhiwei Shao; Lihong Liu; Yanghao Zheng; Sheng Tu; Yuanbo Pan; Sheng Yan; Qichun Wei; Anwen Shao; Jianmin Zhang
Journal:  Front Oncol       Date:  2020-09-11       Impact factor: 6.244

4.  Inhibitory effect of miR-140-5p on doxorubicin resistance of hepatocellular carcinoma.

Authors:  Xiaojie Gao; Yan Jiang; Yingying Li
Journal:  Exp Ther Med       Date:  2021-03-18       Impact factor: 2.447

Review 5.  Growing Evidence of Exosomal MicroRNA-Related Metastasis of Hepatocellular Carcinoma.

Authors:  Wenbing Sun; Shuqi Fu; Size Wu; Rong Tu
Journal:  Biomed Res Int       Date:  2020-11-27       Impact factor: 3.411

6.  miR-1251-5p Overexpression Inhibits Proliferation, Migration, and Immune Escape in Clear Cell Renal Cell Carcinoma by Targeting NPTX2.

Authors:  Lin Yue; Hualong Lin; Shaofei Yuan; Lili Wu; Guangming Chen; Jiaqi Wang; Jieni Feng
Journal:  J Oncol       Date:  2022-03-10       Impact factor: 4.375

7.  Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors.

Authors:  Qiuju Liang; Jinwu Peng; Zhijie Xu; Zhilan Li; Feng Jiang; Lingzi Ouyang; Shangjun Wu; Chencheng Fu; Ying Liu; Yuanhong Liu; Yuanliang Yan
Journal:  Front Genet       Date:  2022-08-30       Impact factor: 4.772

8.  Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.

Authors:  Fuquan Jiang; Haiguan Lin; Hongfeng Yan; Xiaomin Sun; Jianwu Yang; Manku Dong
Journal:  Eur J Med Res       Date:  2022-10-17       Impact factor: 4.981

9.  Silencing of circRNA circ_0001666 Represses EMT in Pancreatic Cancer Through Upregulating miR-1251 and Downregulating SOX4.

Authors:  Rundong Zhang; Wanli Zhu; Chenchao Ma; Kaixing Ai
Journal:  Front Mol Biosci       Date:  2021-05-13

10.  Diagnostic model of combined ceRNA and DNA methylation related genes in esophageal carcinoma.

Authors:  Xiaojiao Guan; Yao Yao; Guangyao Bao; Yue Wang; Aimeng Zhang; Xinwen Zhong
Journal:  PeerJ       Date:  2020-03-31       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.